Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NewStetic is a leading Latin American healthcare company specializing in the development, manufacture, and commercialization of dental products. Founded in 1954 in Colombia, the company has established a significant global presence, exporting its portfolio to over 60 countries. Its core business segments include local anesthetics, acrylic resins, artificial teeth, and various dental restorative materials. The company is particularly recognized for its pharmaceutical division, which produces widely used dental anesthetics like Newcaina and Roxicaina. NewStetic operates state-of-the-art manufacturing facilities that comply with international quality standards, including GMP and ISO certifications. As a key player in the dental supply chain, the company serves both the public and private healthcare sectors across the Americas and beyond.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NewStetic.